Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

about

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

Item

http://www.wikidata.org/entity/Q42560934

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

@en

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

@nl

type

Item

label

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

@en

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

@nl

prefLabel

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

@en

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

@nl

P1476

Seeing the unseen fibrosis in heart failure with preserved ejection fraction.

@en

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Advances in parametric mapping with CMR imaging

Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping.

Multi-modality imaging of diastolic function.

Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality

T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

P304

998-1000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1016/J.JCMG.2014.05.012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Salerno

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25323162

http://www.w3.org/2001/XMLSchema#string

P932

4405248

http://www.w3.org/2001/XMLSchema#string